Name
Perearst Helle Vambola OÜ
Registry code
12541528
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.09.2013 (11)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
585 961 €
167 369 €
29%
2 045 €
(estimate is approximate)
490 210 €
8
Submitted
No tax arrears
34%
31%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Helle Vambola 10.10.1956 (68) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2019 09.07.2021 | 2020 23.07.2021 | 2021 22.06.2022 | 2022 15.06.2023 | 2023 13.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 261 136 € | 323 286 € | 286 953 € | 397 593 € | 585 961 € |
| Net profit (loss) for the period | 49 056 € | 71 296 € | 41 937 € | 83 063 € | 167 369 € |
| Profit Margin | 19% | 22% | 15% | 21% | 29% |
| Current Assets | 215 010 € | 286 851 € | 308 182 € | 327 715 € | 453 081 € |
| Fixed Assets | 22 977 € | 32 806 € | 46 044 € | 45 330 € | 80 066 € |
| Total Assets | 237 987 € | 319 657 € | 354 226 € | 373 045 € | 533 147 € |
| Current Liabilities | 21 532 € | 31 906 € | 24 538 € | 36 294 € | 42 937 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 216 455 € | 287 751 € | 329 688 € | 336 751 € | 490 210 € |
| Employees | 9 | 9 | 8 | 8 | 8 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 51 317.57 € | 30 449.71 € | 9 |
| 2023 Q4 | - | 26 807.34 € | 28 434.26 € | 9 |
| 2023 Q3 | - | 27 571.36 € | 26 876.74 € | 9 |
| 2023 Q2 | - | 18 713.9 € | 19 883.3 € | 9 |
| 2023 Q1 | - | 23 517.58 € | 25 001.21 € | 9 |
| 2022 Q4 | - | 18 887.75 € | 20 163.66 € | 10 |
| 2022 Q3 | - | 16 265.06 € | 17 378.26 € | 11 |
| 2022 Q2 | - | 31 340.12 € | 13 159.5 € | 9 |
| 2022 Q1 | - | 18 299.55 € | 19 372.13 € | 9 |
| 2021 Q4 | - | 14 553.28 € | 15 471.64 € | 9 |
| 2021 Q3 | - | 14 653.23 € | 15 543.6 € | 9 |
| 2021 Q2 | - | 13 971.56 € | 14 846.26 € | 9 |
| 2021 Q1 | - | 13 464.52 € | 14 337.78 € | 9 |
| 2020 Q4 | - | 16 650.24 € | 17 765.87 € | 9 |
| 2020 Q3 | - | 17 683.79 € | 18 960.41 € | 9 |
| 2020 Q2 | - | 11 345.37 € | 12 138.08 € | 12 |
| 2020 Q1 | - | 12 655.45 € | 13 547.35 € | 9 |
